{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:31:23Z","timestamp":1778232683965,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006019","name":"Van Andel Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["CTF-2021-01-004"],"award-info":[{"award-number":["CTF-2021-01-004"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jid.2024.01.032","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T16:43:14Z","timestamp":1708620194000},"page":"2052-2065.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ex\u00a0Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1\u2013Related Cutaneous Neurofibromas"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-2940","authenticated-orcid":false,"given":"Jamie L.","family":"Grit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-8566","authenticated-orcid":false,"given":"Lisa","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-5282","authenticated-orcid":false,"given":"Curt J.","family":"Essenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-1028","authenticated-orcid":false,"given":"Kristin L.","family":"Gallik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4469","authenticated-orcid":false,"given":"Patrick S.","family":"Dischinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan D.","family":"Shurlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-2034","authenticated-orcid":false,"given":"Matthew J.","family":"Pate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-5642","authenticated-orcid":false,"given":"Carrie R.","family":"Graveel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6730","authenticated-orcid":false,"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.01.032_bib1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41416-018-0073-2","article-title":"Cutaneous neurofibromas in the genomics era: current understanding and open questions","volume":"118","author":"Allaway","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2024.01.032_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.01.032_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0000000000005788","article-title":"The biology of cutaneous neurofibromas: consensus recommendations for setting research priorities","volume":"91","author":"Brosseau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2024.01.032_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-18-0151","article-title":"Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the hippo pathway","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2024.01.032_bib5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fmicb.2019.01172","article-title":"An ex\u00a0vivo Human Skin Model to Study Superficial Fungal Infections","volume":"10","author":"Corzo-Le\u00f3n","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jid.2024.01.032_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.trsl.2023.06.003","article-title":"Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice","volume":"261","author":"Coulpier","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.jid.2024.01.032_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jid.2024.01.032_bib8","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2024.01.032_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0261192920914193","article-title":"The ex\u00a0vivo skin model as an alternative tool for the efficacy and safety evaluation of topical products","volume":"48","author":"Eberlin","year":"2020","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.jid.2024.01.032_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4236\/ijcm.2015.612128","article-title":"A\u00a0proof-of-concept assessment of the safety and efficacy of intralesional diclofenac in the treatment of cutaneous neurofibromas","volume":"06","author":"Geller","year":"2015","journal-title":"Int J Clin Med"},{"key":"10.1016\/j.jid.2024.01.032_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72704-1","article-title":"Vitamin C\u2013squalene bioconjugate promotes epidermal thickening and collagen production in human skin","volume":"10","author":"Gref","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.01.032_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13072-020-00380-6","article-title":"Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK\/p38 signaling","volume":"14","author":"Grit","year":"2021","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jid.2024.01.032_bib13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2024.01.032_bib14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","article-title":"T\u00a0cells and the skin: from protective immunity to inflammatory skin disorders","volume":"19","author":"Ho","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2024.01.032_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42003-018-0163-y","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1","volume":"1","author":"Isakson","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.jid.2024.01.032_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2024.01.032_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.jid.2024.01.032_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41523-020-00204-6","article-title":"S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue","volume":"6","author":"Jindal","year":"2020","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jid.2024.01.032_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/bs.ircmb.2019.03.004","article-title":"Nongenomic glucocorticoid effects and their mechanisms of action in vertebrates","volume":"346","author":"Johnstone","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.jid.2024.01.032_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/abd1806-4841.20175765","article-title":"The role of intradermal proliferation of T-cells in the pathogenesis of psoriasis","volume":"92","author":"Khairutdinov","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2024.01.032_bib21","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.1119407","article-title":"Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2","volume":"310","author":"Kim","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jid.2024.01.032_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5999\/aps.2020.01914","article-title":"Management of keloid scars: noninvasive and invasive treatments","volume":"48","author":"Kim","year":"2021","journal-title":"Arch Plast Surg"},{"key":"10.1016\/j.jid.2024.01.032_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Le","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2024.01.032_bib24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jid.2023.01.041","article-title":"Target product profile for cutaneous neurofibromas: clinical trials to prevent, arrest, or regress cutaneous neurofibromas","volume":"143","author":"Ly","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.01.032_bib25","article-title":"Unbalancing cAMP and Ras\/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas","volume":"9","author":"Mazuelas","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2024.01.032_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139807","article-title":"Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins","volume":"131","author":"Mo","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2024.01.032_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78292-4","article-title":"Human skin explant model for the investigation of topical therapeutics","volume":"10","author":"Neil","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.01.032_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06518","article-title":"Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1","volume":"7","author":"Oliveira","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.jid.2024.01.032_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.1986.tb48079.x","article-title":"Collagens in neurofibromas and neurofibroma cell cultures","volume":"486","author":"Peltonen","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jid.2024.01.032_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","article-title":"Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery","volume":"122","author":"Powley","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2024.01.032_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2024.01.032_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","article-title":"Re-epithelialization and immune cell behaviour in an ex\u00a0vivo human skin model","volume":"10","author":"Rakita","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.01.032_bib33","doi-asserted-by":"crossref","unstructured":"Schmidt U, Weigert M, Broaddus C, Myers G. Cell detection with star-convex polygons. Paper presented at: 21st International Conference on Medical Image Computing and Computer-Assisted Intervention. 16\u201320 September 2018; Granada, Spain.","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"10.1016\/j.jid.2024.01.032_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0906-6705.2006.00428.x","article-title":"Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions","volume":"15","author":"Simon","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.01.032_bib35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jid.2023.01.042","article-title":"Existing and developing preclinical models for neurofibromatosis type 1-related cutaneous neurofibromas","volume":"143","author":"Staedtke","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.01.032_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136262","article-title":"Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry","volume":"5","author":"Tabata","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2024.01.032_bib37","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/s41598-020-61251-4","article-title":"Longitudinal phenotype development in a minipig model of neurofibromatosis type 1","volume":"10","author":"Uthoff","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.01.032_bib38","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.0000000000005791","article-title":"Considerations for development of therapies for cutaneous neurofibroma","volume":"91","author":"Verma","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2024.01.032_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120402","article-title":"A\u00a0porcine model of neurofibromatosis type 1 that mimics the human disease","volume":"3","author":"White","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2024.01.032_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in Desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2024.01.032_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.723846","article-title":"CXCL8 in tumor biology and its implications for clinical translation","volume":"9","author":"Xiong","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jid.2024.01.032_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/1566524011313060007","article-title":"Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy","volume":"13","author":"Zhang","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jid.2024.01.032_bib43","unstructured":"Zaidi M., McKee T., Wouters B. Universal StarDist for QuPath. Version 2.0.0. doi:10.13140\/RG.2.2.36267.11046 2023-03-08."}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:54:25Z","timestamp":1762206865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0022202X24001179"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.01.032","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex\u00a0Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1\u2013Related Cutaneous Neurofibromas","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}